Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide DecanoateBusiness Wire • 05/07/26
6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market Crash24/7 Wall Street • 05/06/26
Merck Animal Health Selects Salesforce's Agentforce Life Sciences for Customer Engagement to Transform Animal Care and Enhance Support Experiences for EmployeesBusiness Wire • 05/06/26
Merck Stock Looks Undervalued as KEYTRUDA Growth and Pipeline Offset Near-Term Headwinds24/7 Wall Street • 05/05/26
Warren Buffett Owns 2 of the Small Dogs of the Dow: Here's Why You Need to Own All 524/7 Wall Street • 05/04/26
Merck: 'Strong Buy' - Terns Acquisition And Ability To Counter Keytruda Patent LossSeeking Alpha • 05/03/26
MRK Q1 Earnings & Sales Beat Estimates, 2026 Sales View TightenedZacks Investment Research • 04/30/26
Merck (MRK) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 04/30/26
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin ManifestationsBusiness Wire • 04/30/26
Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlookCNBC • 04/30/26
Dow Jones' Merck Tops Forecasts, But Growth Products Come Up MixedInvestors Business Daily • 04/30/26
Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical MilestonesBusiness Wire • 04/30/26
Merck's Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or StrokeBusiness Wire • 04/28/26